№ lp_1_2_21880
File format: docx
Character count: 2514
File size: 59 KB
This document is a form used by the study team to document the withdrawal of a participant from a clinical study and to ensure that the participant’s consent and decisions regarding the continuation of treatment and participation are clearly recorded.
Year:
Not provided
Region / City:
Not provided
Subject:
Medical Research, Participant Consent
Document Type:
Study Form
Organ / Institution:
Not provided
Author:
Not provided
Target Audience:
Study team, Research Participants
Period of Validity:
Not provided
Approval Date:
Not provided
Amendment Date:
Not provided
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
n/a
Region / City:
n/a
Topic:
Public health practice, ethical review
Document type:
Report
Agency/Organization:
CDC
Author:
Teresa C. Horan, BS, MPH
Target audience:
n/a
Effective period:
n/a
Approval date:
n/a
Amendment date:
n/a
Year:
2021
Region / City:
Canberra
Topic:
Alcohol withdrawal management
Document Type:
Guideline
Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical and nursing staff, students under supervision
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Last Revision:
Not specified
Year:
2023
Region / City:
Canberra
Subject:
Land Titles
Document Type:
Guidance Note
Organization / Institution:
Access Canberra
Author:
Not specified
Target Audience:
Legal practitioners, self-represented parties, mortgagees
Effective Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2020
Region / City:
United States
Subject:
Alcohol withdrawal syndrome, Benzodiazepine-sparing regimens, Inpatient outcomes
Document type:
Research Article
Organization / Institution:
Not specified
Author:
Joshua T. Smith, Mary Sage, Herb Szeto, Yun Lu, Adriana Martinez, Patricia Kipnis, Vincent X. Liu
Target audience:
Healthcare professionals, medical researchers
Period of validity:
2018-2019
Approval date:
Not specified
Date of changes:
Not specified
Note:
Context
Note:
Year
Theme:
Mental health, substance use disorder
Document Type:
Quick Reference Guide
Organization:
Sunshine Mental Health and Wellbeing Centre
Target Audience:
Clinical staff, healthcare professionals
Review Date:
Every 2 years
Note:
Year
Consumptive Loss:
The water removed from an available raw water source without returning to the same source.
Water Loss:
The difference between the volume of water supplied to a system and volume of water used in the industrial process.
Date:
_____________
Year:
2022
Region / city:
Canberra
Topic:
Alcohol withdrawal treatment
Document type:
Procedure
Organization / institution:
Canberra Health Services
Author:
Unknown
Target audience:
Medical and nursing staff at Alcohol and Drug Service (ADS)
Period of validity:
Not specified
Approval date:
17 June 2022
Revision date:
Not specified
Year:
1999
Region / city:
Australia
Topic:
Health / Substance Withdrawal
Document type:
Questionnaire
Organization:
National Centre for Education and Training on Addiction (NCETA)
Author:
Srisurapanont, M., Jarusuraisin, N., Jittiwutikan, J., Fischer, J.A., Roche, A.M., Duraisingam, V.
Target audience:
Healthcare professionals, researchers
Effective period:
N/A
Approval date:
N/A
Date of changes:
N/A
Year:
2019
Note:
Region / city
Subject:
Finance
Document type:
Consultation Paper
Institution:
Central Bank
Contextual description:
A consultation paper detailing the procedure for withdrawing approval of a sub-fund and the required documentation for the process.
Year:
2025
Region / City:
Wisconsin
Theme:
Public health, disability services
Document type:
Form, Request
Agency:
Department of Health Services, Division of Public Health
Author:
Not specified
Target audience:
IRIS participants, legal guardians, representatives
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2024
Region / city:
Australia
Topic:
Renewable energy, certification, and regulatory compliance
Document type:
Form
Agency:
Clean Energy Regulator
Target audience:
Registered profile holders in the PGO system
Effective date:
2024
Date of approval:
03/11/2025
Withdrawal option:
Yes
Signature required:
Yes
Contact information:
[email protected]
Method of submission:
Email
Form completion method:
Electronic or hand-written
Context:
This document is a form to notify authorisations, transfers, or withdrawals related to the Product Guarantee of Origin (PGO) certificates, in accordance with the Future Made in Australia (Guarantee of Origin) Act 2024.
Note:
Year
Organization / Institution:
University of Surrey
Target Audience:
Students
Year:
2021
Region / city:
South Africa
Topic:
Retirement Savings Withdrawal
Document type:
Form
Organization:
Fairsure Administration
Author:
Fairsure Administration
Target audience:
Fund members
Effective period:
From 1 March 2021
Approval date:
Not specified
Modification date:
Not specified
Year:
not specified
Country:
United Kingdom
Medication:
Zopiclone
Therapeutic class:
Hypnotic
Indication:
Insomnia
Licensed use duration:
Up to 4 weeks
Adult licensed dose:
7.5 mg at bedtime
Elderly licensed dose:
3.75–7.5 mg at bedtime
Off-licence use:
Yes
Primary topic:
Dose reduction and withdrawal
Withdrawal risks:
Physical and psychological withdrawal symptoms
Target population:
Adult patients using zopiclone long term
Recommended tapering pace:
No faster than one change per week
Dose forms:
3.75 mg tablets, 7.5 mg tablets
Reference bodies:
All Wales Medicines Strategy Group; NICE
Document components:
Clinical guidance; tapering schedule; patient reduction record
Note:
Year
Organization / Institution:
Wilson Workforce and Rehabilitation Center
Target Audience:
Applicants to the Wilson Workforce and Rehabilitation Center
Note:
Year
Institution:
Auckland University of Technology
Year:
2024
Region / City:
Not specified
Topic:
Non-SIT S&A Qualification Testing
Document Type:
Report
Organization / Institution:
Non-SIT S&A QT Team
Author:
Non-SIT S&A QT Team
Target Audience:
Program participants involved in Non-SIT S&A QT
Effective Period:
Not specified
Approval Date:
02-Sep-2024
Amendment Date:
Not specified
Note:
Year
Subject:
Research
Document Type:
Information Sheet
Organization / Institution:
University of Technology Sydney
Author:
[insert name]
Target Audience:
Potential participants in the research study
Period of Activity:
[insert period if available]
Approval Date:
[insert approval date if available]
Date of Amendments:
[insert amendments date if available]
Note:
Year
Organization / Institution:
UN Environment Programme (UNEP)
Target Audience:
Insurance organizations, stakeholders in climate action